Inventor · disambiguated record
Stuart Flanagan
Also filed as: FLANAGAN STUART · FLANAGAN STUART ROBERT
8 granted patents·2 pending applications·6 citations·filing 2008–2024
78Inventor score
Top patents by PatentIndex Score
10 records- 0178US9732085B2Pyridinone and pyrimidinone derivatives as factor XiaONO PHARMACEUTICAL CO·Filed 2012·Granted Aug 15, 2017·5 cites·9 claims
- 0273US9585881B2Substituted pyrrolidines as factor XIa inhibitors for the treatment thromboembolic diseasesONO PHARMACEUTICAL CO·Filed 2016·Granted Mar 7, 2017·1 cites·4 claims
- 0371US12162895B2DNA polymerase theta inhibitor for treatment of cancerBREAKPOINT THERAPEUTICS GMBH·Filed 2024·Granted Dec 10, 2024·0 cites·6 claims
- 0471US12145945B2Compounds, compositions, and therapeutic uses thereofBREAKPOINT THERAPEUTICS GMBH·Filed 2024·Granted Nov 19, 2024·0 cites·4 claims
- 0569US2021147403A1Substituted pyrrolidines as factor xia inhibitors for the treatment thromboembolic diseasesONO PHARMACEUTICAL CO·Filed 2020·Application pending·0 cites
- 0666US10882855B2Substituted pyrrolidines as factor XIa inhibitors for the treatment thromboembolic diseasesONO PHARMACEUTICAL CO·Filed 2019·Granted Jan 5, 2021·0 cites·13 claims
- 0761US9394250B2Substituted pyrrolidines as factor xia inhibitors for the treatment thromboembolic diseasesONO PHARMACEUTICAL CO·Filed 2013·Granted Jul 19, 2016·0 cites·2 claims
- 0857US10336741B2Substituted pyrrolidines as factor XIa inhibitors for the treatment thromboembolic diseasesONO PHARMACEUTICAL CO·Filed 2017·Granted Jul 2, 2019·0 cites·10 claims
- 0953US10717738B2Pyrimidinone and its derivatives inhibiting factor XIaONO PHARMACEUTICAL CO·Filed 2017·Granted Jul 21, 2020·0 cites·14 claims
- 1044US2009215778A1Alpha-substituted Arylmethyl Piperazine Pyrazolo [1,5-alpha]Pyrimidine Amide DerivativesPANACOS PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stuart Flanagan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →